The U.S. National Cancer Institute (NCI) of the National Institutes of Health has awarded a five-year, $500,000-per-year grant to researchers from George Washington University (GW) School of Medicine and Health Sciences.
The funds will be used to develop proteomic biomarkers for bile duct cancer induced by the liver fluke Opisthorchis viverrini.
GW's School of Medicine and Health Sciences will use a quantitative proteomics approach to scan tumor tissues and matched plasma from bile duct cancer patients to identify a suite of candidate biomarkers proximal to the disease site.
